Applied DNA Sciences Inc. a leader in Polymerase Chain Reaction -based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, announced consolidated financial results for the fiscal second quarter and the six months ended March 31, 2020.
May 14, 2020
· 16 min read